2021 annual financial data
Sutro Biopharma, Inc. 2021 Operating cash flow margin
Sutro Biopharma, Inc. 2021 operating cash flow margin with verified reported va…
Direct answer
Operating cash flow margin was -132%.
Operating income was -98,524,000 USD and net income was -105,538,000 USD.
Operating cash flow was -81,679,000 USD.
Get free Sutro Biopharma, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 61,880,000 USD
- Operating income
- -98,524,000 USD
- Net income
- -105,538,000 USD
- Operating cash flow
- -81,679,000 USD